Biotechnology need not break the bank

    loading  Checking for direct PDF access through Ovid

Abstract

Pharmacists are using a variety of techniques to ensure that pharmaceuticals produced by recombinant technology improve patient outcomes without blowing pharmacy budgets. Recombinant granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) were the focus of several presentations at the 28th Midyear Clinical Meeting of the American Society of Hospital Pharmacists, held in Atlanta, Georgia last December. Key areas in which pharmacists participate in optimising the use of these drugs include exploiting synergistic effects of treatment, determining treatment guidelines and minimising inappropriate use of these high-price agents.

Related Topics

    loading  Loading Related Articles